Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ So-Young International Inc. (SY) Stock Forecast & Price Prediction China | NASDAQ | Healthcare | Health Information Services
$1.69
-0.15 (-8.15%)Did SY Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if So-Young is one of their latest high-conviction picks.
Based on our analysis of 2 Wall Street analysts, SY has a bullish consensus with a median price target of $7.33 (ranging from $4.82 to $9.84). The overall analyst rating is Strong Buy (10.0/10). Currently trading at $1.69, the median forecast implies a 333.8% upside. This outlook is supported by 2 Buy, 0 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for SY.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jul 8, 2025 | Citigroup | Nelson Cheung | Buy | Upgrade | $5.50 |
| Sep 23, 2024 | Citigroup | Neutral | Downgrade | $N/A | |
| Mar 23, 2023 | Jefferies | Buy | Maintains | $N/A | |
| Mar 22, 2023 | Citigroup | Buy | Upgrade | $N/A | |
| Nov 26, 2021 | Needham | Buy | Maintains | $N/A | |
| Mar 23, 2021 | Canaccord Genuity | Buy | Maintains | $N/A | |
| Mar 23, 2021 | Needham | Buy | Maintains | $N/A | |
| Aug 28, 2020 | Needham | Buy | Maintains | $N/A | |
| May 19, 2020 | Canaccord Genuity | Buy | Maintains | $N/A | |
| Mar 24, 2020 | Needham | Buy | Maintains | $N/A | |
| Jun 10, 2019 | CICC | Buy | Initiates | $N/A | |
| May 31, 2019 | Canaccord Genuity | Buy | Maintains | $N/A | |
| May 28, 2019 | Needham | Buy | Initiates | $N/A | |
| May 28, 2019 | Canaccord Genuity | Buy | Initiates | $N/A |
The following stocks are similar to So-Young based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
So-Young International Inc. has a market capitalization of $167.64M with a P/E ratio of 17.2x. The company generates $244.92M in trailing twelve-month revenue with a -15.6% profit margin.
Revenue growth is +45.6% quarter-over-quarter, while maintaining an operating margin of -13.4% and return on equity of -15.0%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Medical aesthetics service platform in China.
The company generates revenue by connecting consumers with providers of cosmetic and wellness treatments through its online platform. It offers appointment reservation services and digital marketing tools to service providers, facilitating patient acquisition and enhancing user engagement.
So-Young International Inc. operates in a growing market at the intersection of healthcare, consumer internet, and beauty services. Founded in 2013 and headquartered in Beijing, the company leverages online content and community features to enhance its service offerings.
Healthcare
Health Information Services
2,348
Mr. Xing Jin
China
N/A
Shares of Here Group, Zepp Health, Burning Rock Biotech, and So-Young International saw significant gains last year but have lost most of those gains in 2026.
The decline in shares of Here Group, Zepp Health, Burning Rock Biotech, and So-Young International indicates potential volatility and risk, impacting investor confidence and future buying decisions.
So-Young International's rating is downgraded from 'Buy' to 'Hold' following mixed 1Q2026 results: 46% YoY revenue growth but increased net losses due to lower online margins and expansion costs.
The downgrade to 'Hold' indicates caution amid mixed performance, with strong revenue growth overshadowed by widening losses, signaling potential volatility for investors in So-Young International.
So-Young International (NASDAQ: SY) reported significant Q1 2026 revenue growth, fueled by its branded aesthetic center business expansion and investments in standardized medical delivery.
So-Young's revenue growth and expansion efforts signal strong demand in the aesthetic market, potentially enhancing profitability and investor confidence in future performance.
So-Young International Inc. (SY) held its Q1 2026 earnings call, discussing financial performance and key business developments. Further details can be reviewed in the full transcript.
The Q1 2026 earnings call reveals So-Young International's financial performance, impacting stock valuation and investor sentiment regarding future growth prospects.
So-Young International Inc. reported Q1 2026 revenues of RMB432.8 million (US$62.7 million), up from RMB297.3 million in Q1 2025, indicating strong growth for the company.
So-Young's revenue growth of over 45% year-on-year indicates strong demand in the aesthetic treatment sector, potentially enhancing investor confidence and stock performance.
So-Young International Inc. (NASDAQ: SY) will report Q1 2026 financial results on May 22, 2026, before U.S. markets open, with a conference call scheduled for 7:30 AM ET.
So-Young's upcoming earnings report may influence its stock price and investor sentiment, reflecting the company's performance in China's aesthetic treatment market.
Based on our analysis of 2 Wall Street analysts, So-Young International Inc. (SY) has a median price target of $7.33. The highest price target is $9.84 and the lowest is $4.82.
According to current analyst ratings, SY has 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $1.69. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict SY stock could reach $7.33 in the next 12 months. This represents a 333.8% increase from the current price of $1.69. Please note that this is a projection by Wall Street analysts and not a guarantee.
The company generates revenue by connecting consumers with providers of cosmetic and wellness treatments through its online platform. It offers appointment reservation services and digital marketing tools to service providers, facilitating patient acquisition and enhancing user engagement.
The highest price target for SY is $9.84 from at , which represents a 482.3% increase from the current price of $1.69.
The lowest price target for SY is $4.82 from at , which represents a 185.2% increase from the current price of $1.69.
The overall analyst consensus for SY is bullish. Out of 2 Wall Street analysts, 2 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $7.33.
Stock price projections, including those for So-Young International Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.